Immunohematological characteristics of Nigerian sickle cell disease patients with osteomyelitis by Elkanah Ayodele Orimolade & Lateef Salawu
145 Research Article
Immunohematological characteristics of Nigerian 
sickle cell disease patients with osteomyelitis
Osteomiyeliti olan Nijeryal› orak hücre hastal›¤›na sahip kiﬂilerin 
immünohematolojik özellikleri
Elkanah Ayodele Orimolade1, Lateef Salawu2
1Department of Orthopaedics & Traumatology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria
2Department of Haematology & Blood Transfusion, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria
Address for Correspondence: Dr. Lateef Salawu, Obafemi Awolowo University Teaching Hospitals Complex, Ile-ife, Nigeria
Phone: +234 8033884177 E-mail: lsalawu2002@yahoo.co.uk
Abstract
Objective: We aimed in this paper to investigate some immunohematological characteristics of Nigerian sickle cell 
anemia (SCA) patients with osteomyelitis.
Material and Methods: Thirty SCA patients with osteomyelitis (SO) and 30 SCA patients without osteomyelitis (S) were
investigated. The PCV, WBC and platelet count were done on automated counter, while the erytorocyte sedimentation
rate (ESR) was determined by Westergren’s technique. C3 activator, C1-INH, IgA, IgG and IgM were estimated by the 
single radial immunodiffusion method. 
Results: The SO patients weighed less (z =1.943, p<0.055) and were shorter (z = -2.064, p<0.039). High serum 
levels of IgG, IgM, C1-INH and C3 activator were also found in the SO group. ESR correlated positively with hematocrit 
(r=0.371, p<0.04) and C3 activator (r=0.468, p<0.03) in SO. Similarly, WBC correlated positively with C1-INH 
(r=0.806, p<0.01), while we also noted positive correlation between C1-INH and C3 activator (r=0.525, p<0.02). In SO,
ESR correlated positively with both IgM (r=0.531, p<0.02) and C3 activator (r=0.449, p<0.05).
Conclusion: This study suggests some derangement in immune status in Nigerian SCA patients with osteomyelitis and that
C1-INH and C3 activator may be useful markers of immune status in SCA patients. (Turk J Hematol 2008; 25: 145-8)
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Özet
Amaç: Osteomiyeliti olan Nijeryal› orak hücre anemisine sahip kiﬂilerin immünohematolojik özelliklerinin araﬂt›r›lmas›.
Gereç ve Yöntemler: Osteomiyeliti olan 30 Sickle Cell Anemi (SCA) hastas› (SO) ve osteomiyeliti olmayan 30 SCA has-
tas› (S) araﬂt›r›lm›ﬂt›r. Eritrosit sedimentasyon h›z› (ESR), Westergren tekni¤iyle belirlenirken PCV, WBC ve trombosit say›m›
otomatik bir sayaçla yap›lm›ﬂt›r. C3 aktivatör, C1-INH, IgA, IgG ve IgM tek radial immünodiffüzyon yöntemi ile
hesaplanm›ﬂt›r. 
Bulgular: SO daha hafif (z = 1,943, p<0.055) ve daha k›sad›r (z = -2,064, p<0.039). SO’da IgG, IgM, C1-INH ve C3 akti-
vatör serum seviyeleri yüksektir. SO’da ESR, hematokrit (r=0,371, p<0,04) ve C3 aktivatör (r=0,468, p<0,03) ile pozitif
olarak koreledir. Benzer ﬂekilde WBC, C1-INH (r=0,806, p<0,01) ile pozitif olarak koreledir. Ayr›ca C1-INH ve C3 aktivatör
(r=0,525, p<0,02) aras›nda da pozitif bir korelasyon belirledik. SO’da ESR, IgM (r=0,531, p<0,02) ve C3 aktivatör (r=0,449,
p<0,05) ile pozitif olarak koreledir. 
Sonuç: Bu çal›ﬂmaya göre, osteomiyeliti olan Nijeryal› SCA hastalar›n›n immün durumu biraz kar›ﬂ›kt›r ve C1 INH ile C3
aktivatör, SCA hastalar›ndaki ba¤›ﬂ›kl›k durumunun faydal› belirteçleri olabilir. (Turk J Hematol 2008; 25: 145-8)
Anahtar kelimeler: Kemik, bakteriyel enfeksiyon, hemoglobinopati, osteomiyelit, orak hücreli anemi.
Geliﬂ tarihi: 19 Kas›m 2007 Kabul tarihi: 9 Ocak 2008Introduction
Bone involvement in the form of painful vaso-occlusive crisis,
osteomyelitis, bone necrosis, chronic arthritis, and impaired
growth are common manifestations of sickle cell disease (SCD)
[1]. The microvascular circulation of the bones is a common site
for sickled red cells to lodge, leading to thrombosis, infarction,
and necrosis of the bone [2,3]. Infarcted bones are easily 
colonized by bacteria following an episode of bacteremia [4],
which could result from intravascular sickling of the bowel 
vessels as found in other tissues of patients with SCD. This may
lead to ischemic infarction and devitalization of the bowel, 
thereby permitting loss of mucosal barrier [5] with consequent
bacteremia. Other factors predisposing the SCD patients to
infections, especially from encapsulated organisms, include
abnormal antibody production, defective splenic function, and
defects in the alternate complement pathway, leukocyte 
function, and cell-mediated immunity [6,7]. 
Clinical signs and symptoms include pain, swelling and 
tenderness over the affected bone area and fever [8]. These
same clinical signs and symptoms also feature prominently in
vaso-occlusive crisis and as such make the diagnosis of
osteomyelitis in SCD subjects sometimes difficult. The objective
of this study was to investigate some laboratory parameters that
may aid in the diagnosis of osteomyelitis in sickle cell anemia
(SCA) patients. 
Materials and Methods
SCA patients with osteomyelitis who presented to the
Orthopedic and Hematology Clinics of the Obafemi Awolowo
University Teaching Hospitals Complex (OAUTHC), Ile-Ife,
between November 2003 and March 2005 were recruited into
the study. Age- and sex-matched SCA patients in steady state
without osteomyelitis were enrolled as controls.
Each patient was assessed clinically for features of
osteomyelitis. These include the presence of painful skeletal
swelling, warmth, tenderness and decreased motion of the
affected part of the limb. Some demographic data (age, gender,
weight and height) of both the subjects and controls were also
documented. Diagnosis of osteomyelitis was confirmed by 
isolation of the infecting organism(s) from the wound and/or 
tissue biopsy culture. Wound swabs and tissue biopsies were
taken under sterile theater condition to avoid culturing 
contaminants. Aseptic techniques were also observed in blood
sample collection to avoid culturing skin commensals. The 
characteristic radiological features were also noted. Blood 
samples were also taken from both the subjects and controls, in
appropriate bottles, for blood counts packed cell volume [PCV],
white blood cells [WBCs] and differentials, platelets, erythrocyte
sedimentation rate [ESR], serum immunoglobulins (IgG, IgM,
and IgA) and complement regulator proteins (C1 esterase
inhibitor [C1-INH] and C3 activator). Hematological parameters
were estimated within six hours of sample collection, while
serum for Igs and complement protein samples were stored 
at -20oC and estimated in batches.
The PCV, WBCs and differentials, and platelet counts were
done on automated counter (ADVIA-60 Bayer Corporation, New
York), while ESR was determined by Westergren’s technique [9].
C3 activator, C1-INH, IgA, IgG and IgM were estimated by the
single radial immunodiffusion method of Salimonu et al. [10],
using monospecific antisera (Dade Behring, Germany). 
Data are presented as means and standard deviation 
(means ± SD). Mann-Whitney U test was used to test the 
significance of differences between mean values. Spearman’s
correlation coefficient were computed where necessary.
Probability (p) value greater than 0.05 was considered insignifi-
cant. 
Results
Demographic Variables
Sixty patients with SCA were investigated. Their clinical and
immunohematological characteristics are as documented in
Table 1. They included 30 SCA subjects with osteomyelitis (SO)
and 30 age- and sex-matched SCA subjects in steady state
without osteomyelitis (S). Of the 30 SCA subjects with
osteomyelitis, male to female ratio was 1:1. The 30 age- and
sex-matched SCA patients without osteomyelitis included 12
males and 18 females, with a male to female ratio of approxi-
mately 1:1.5. The SCA patients without osteomyelitis were sig-
nificantly heavier (30.7 ± 15.4kg and 38.8 ± 16.1kg, respective-
ly; z = 1.943, p < 0.055) and taller (126.9 ± 35.9cm and 144.6
±25.1cm, respectively; z = -2.064, p < 0.039) than those with
osteomyelitis.   
Immunohematological Characteristics
The hematocrit was not significantly different between SCA
subjects with (22.7 ± 3.8%) and without (22.2 ± 4.7%)
osteomyelitis. The total white cells count was higher in the SCA
subjects with osteomyelitis (13235 ± 6296 per cubic millimeter
[/cmm] and 11716 ± 4594/cmm, respectively), but the difference
was not significant (z=0.745, p<0.451). The platelet counts
(265000 ± 72246 and 197517 ± 82706/cmm, respectively) and
the ESR (70 ± 44.8 mm/hr and 36.9 ± 34.7 mm/hr, 
respectively) were significantly higher in SCA subjects with
Table 1. Demographic and laboratory parameters of SCD
patients with (SO) and without (S) osteomyelitis
P Pa ar ra am me et te er rs s S SO O   ( (n n= =3 30 0) ) S S   ( (n n= =3 30 0) ) z z- -v va allu ue e p p- -v va allu ue e
Weight (kg) 30.7 ± 15.4 38.8 ± 16.2 1.943 0.055
Height (cm) 126.9 ± 35.9 144.6 ± 25.1 -2.064 0.039
PCV (%) 22.7 ± 3.8 22.2 ± 4.7 0.416 0.678
WBC (/cmm) 13235 ± 6296 11716 ± 4594.3 0.754 0.451
Platelets (10e9/L)  265 ± 72 197 ± 827 3.688 0.0002
ESR (mm/hr) 70 ± 44.8 36.9 ± 34.7 3.196 0.0014
IgG (mg/dl) 700.6± 179.4 644.5 ± 171.2 1.042 0.297
IgA (mg/dl) 217.3 ± 78.3 249 ± 94.9 -1.036 0.300
IgM (mg/dl) 123.1 ± 130.6 93.4 ± 100.7 1.008 0.314 
C1-INH (mg/dl) 32.2 ± 23.8 27 ± 20.2 0.894 0.371
C3 act (mg/dl) 25.7 ± 13.8 17.1 ± 7.4 1.984 0.0147
SO: Sickle cell with osteomyelitis, S: Sickle cell without osteomyelitis, PCV: Packed cell 
volume, WBC: White blood cell, ESR: Erythrocyte sedimentation rate, Ig: Immunoglobulin,
C1-INH: C1 esterase inhibitor, C3 act: C3 activator, cmm: /cmm = per cubic milliliters,
mm/hr = milliliters in the first one hour, mg/dl = milligrams per deciliter. 
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respectively). The ESR and PCV showed negative correlation in
both groups (SO: r = -0.371, p<0.04; S: r = -0.364, p<0.05). In
the SCA patients with osteomyelitis, a strong positive 
correlation was found between white cells count and C1-INH 
(r=0.806, p<0.01), and between ESR and C3 activator 
(r=0.468, p<0.03), while in the SCA subjects without
osteomyelitis, the ESR showed significant positive correlation
with IgM (r=0.531, p<0.02) and C3 activator (r=0.449, p<0.05).
It is also interesting to note the positive correlation between C3
activator and C1-INH (r=0.525, p<0.02) in SCA subjects with
osteomyelitis. The mean serum levels of IgG 
(SO = 700.6 ± 179.4 mg/dl, S = 644.5 ± 171.16 mg/dl), IgM 
(SO = 123.1± 130.6 mg/dl, S = 93.4 ± 100.7 mg/dl), and 
C1-INH (SO = 32.2 ± 23.8 mg/dl, S = 17.1 ± 7.35 mg/dl) were
found to be higher in SCA subjects with osteomyelitis but 
differences were not significant. Conversely, serum IgA 
(SO = 217.3 ± 78.3 mg/dl, S = 249 ± 94.9 mg/dl) was found to
be higher in SCA subjects without osteomyelitis, but the 
difference was also not significant. The mean serum level of C3
activator (SO = 25.7 ± 13.8 mg/dl, S = 17.1 ± 7.35 mg/dl) was
significantly higher in SCA subjects with osteomyelitis (z = 1.984,
p<0.047).
Wound Cultures
The majority of cultures grew Staphylococcus aureus (57.7%
or 15/26). Pseudomonas species were isolated in 26.9% (7/26),
while the remaining 4 (15.4%) isolates were identified as
Escherichia coli. Interestingly, none of the cultures yielded
Salmonella species.
Discussion
Osteomyelitis is regarded as the commonest orthopedic 
disease in developing countries, including Nigeria [11]. The
chronicity of the illness in most cases decreases the quality of
life, especially when it afflicts SCD patients who already have to
cope with other forms of medical problems peculiar to the 
disorder, most especially bone pain. This combination has both
psychosocial and financial implications on the patients and/or
their relations.
The SCA subjects with osteomyelitis were significantly 
shorter and weighed less than those without osteomyelitis 
(z = -2.064, p<0.039; z = 1.943, p<0.055, respectively). The
SCA patients with osteomyelitis also had slightly higher total
leukocytes and neutrophil differentials. The increased leukocytes
could be a result of increased mature neutrophils, which is usual
in SCD [12] and which could be further enhanced by infection
(osteomyelitis). The thrombocytosis could result from
autosplenectomy, as the spleen could pool between 20-40% of
the total body platelets [12] that become available in the 
circulation when the spleen is nonfunctional. Leukocytosis and
thrombocytosis are part of the acute phase changes [13] that
may accompany infection, trauma, surgery, cancer, burns, 
tissue infarction, and various immunologically mediated and
crystal-induced inflammatory conditions. 
Erythrocyte sedimentation is slow even with marked anemia
in SCD subjects due to the abnormal shape of the sickled cells,
which prevent rouleaux formation [14], a process that enhances
red cell sedimentation. The significantly high ESR recorded in
SCA patients with osteomyelitis could therefore only be
explained on the basis of infection, which is also a recognized
cause of elevated ESR [15]. However, the study confirms the
negative relationship between ESR and hematocrit in both 
subjects and controls. 
The complement protein C1 esterase inhibitor (C1-INH) is an
acute phase protein [13], the plasma level of which can possibly
increase in acute phase responses. Although the higher values
recorded in SCA patients with osteomyelitis were not 
statistically significant when compared to those without
osteomyelitis, there was a strong positive correlation 
between C1-INH and white cell count in patients 
with osteomyelitis (r=0.806, p<0.01), another marker of infection
[13], thereby suggesting its possible usefulness as a marker of
infection. The mean serum level of C3 activator was found to be
significantly high in SCA patients with osteomyelitis compared to
those without osteomyelitis (z = 1.984, p < 0.047). C3 activator,
also known as factor B, is a positive acute phase protein [13],
the serum level of which is expected to rise with inflammatory
conditions. Interestingly, a positive correlation was also found
between ESR, an acute phase response marker, and C3 activa-
tor in SCA subjects with osteomyelitis (r=0.468, p<0.03), sug-
gesting that this complement protein could also be a marker of
infection. The possible usefulness of these two 
complement proteins (C1-INH and C3 activator) as independent
markers of infection is further supported by the positive 
correlation that was found between the two proteins 
(r=0.525, p<0.02) in SCA patients with osteomyelitis.
The majority of our isolates were identified as
Staphylococcus aureus. This is in line with some recent reports
from Nigeria [16-18]. Similar to other reports from Nigeria [16,
17], no Salmonella organisms were isolated. The decreasing
incidence of Salmonella species isolation may be due to the
over-diagnosis of typhoid fever based on Widal test and 
treatment for the same by many private medical practitioners. 
It could be concluded that the higher serum levels of IgG,
IgM, C1-INH and C3 activator in SCA patients with osteomyelitis
coupled with the strong positive correlation found between the
traditional markers of infection (elevated ESR and leukocytosis)
and IgM, C1-INH and C3 activator reinforces their being classed
as acute phase response markers. These findings also suggest
that they may be useful markers of infection/osteomyelitis in a
clinical setting suggestive of bone infection, thereby suggesting
early aggressive management in such patients to prevent 
chronic osteomyelitis, which is difficult to treat. The type of 
isolates from most of our patients, as observed recently, is also
informative as to the choice of antibiotic before culture reports
are available. 
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